| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;106:2946.)
© 2002 American Heart Association, Inc.
Clinical Investigation and Reports |
-1 Adrenergic Agonist and a ß-1 Adrenergic Antagonist in Chronic Orthostatic Intolerance
From the Departments of Pediatrics (J.M.S., A.W., J.M.) and Physiology (J.M.S.), New York Medical College, Valhalla, NY.
Correspondence to Julian M. Stewart, MD, PhD, Professor of Pediatrics and Physiology, Suite 618, Munger Pavilion, New York Medical College, Valhalla, NY 10595. E-mail stewart{at}nymc.edu
Background Adrenergic agents are commonly used in the treatment of chronic orthostatic intolerance with postural tachycardia syndrome (POTS). POTS may be associated with increased limb blood flow ("high flow") and defective orthostatic vasoconstriction or decreased limb blood flow ("low flow") and potentially with small blood volume.
Methods and Results We investigated the consequences of short-term intravenous administration of an
-1 adrenergic agonist, phenylephrine, and a ß-1 adrenergic antagonist, esmolol, in 14 patients with POTS aged 13 to 19 years. Indices of heart rate and blood pressure variability, peripheral blood flow, and arterial resistance were assessed, and the capacitance relation was computed for every subject using venous occlusion plethysmography. Patients were tilted to 35° upright while medicated and while unmedicated, and measurements were repeated. Phenylephrine improved orthostatic tolerance and normalized hemodynamics and indices of heart rate/blood pressure variability while supine and while upright, producing significant peripheral vasoconstriction and venoconstriction (20% capacitance change). Esmolol did not improve orthostatic tolerance or hemodynamics. A subgroup of low-flow POTS patients had exaggerated venoconstriction to phenylephrine (50% capacitance change) but others had no response.
Conclusions Phenylephrine, but not esmolol, improves orthostatic tolerance and hemodynamics in POTS. This lends support to the use of oral
-1 agonists in the treatment of patients with chronic orthostatic intolerance.
Key Words: blood flow vasoconstriction heart rate
This article has been cited by other articles:
![]() |
U. Graham and K. M Ritchie Postural orthostatic tachycardia syndrome BMJ Case Reports, April 19, 2009; 2009(apr19_1): bcr1020081132 - bcr1020081132. [Abstract] [Full Text] |
||||
![]() |
S. Carew, M. O. Connor, J. Cooke, R. Conway, C. Sheehy, A. Costelloe, and D. Lyons A review of postural orthostatic tachycardia syndrome Europace, January 1, 2009; 11(1): 18 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Vinik and D. Ziegler Diabetic Cardiovascular Autonomic Neuropathy Circulation, January 23, 2007; 115(3): 387 - 397. [Full Text] [PDF] |
||||
![]() |
S. Debrus, L. Rahbani, M. Marttila, B. Delorme, P. Paradis, and M. Nemer The Zinc Finger-Only Protein Zfp260 Is a Novel Cardiac Regulator and a Nuclear Effector of {alpha}1-Adrenergic Signaling Mol. Cell. Biol., October 1, 2005; 25(19): 8669 - 8682. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Raj, B. K. Black, I. Biaggioni, P. A. Harris, and D. Robertson Acetylcholinesterase Inhibition Improves Tachycardia in Postural Tachycardia Syndrome Circulation, May 31, 2005; 111(21): 2734 - 2740. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Romano, C. Lazzeri, M. Chiostri, G. F. Gensini, and F. Franchi Beat-to-beat analysis of pressure wave morphology for pre-symptomatic detection of orthostatic intolerance during head-up tilt J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1891 - 1897. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Stewart and L. D. Montgomery Regional blood volume and peripheral blood flow in postural tachycardia syndrome Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1319 - H1327. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aries, P. Paradis, C. Lefebvre, R. J. Schwartz, and M. Nemer Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity PNAS, May 4, 2004; 101(18): 6975 - 6980. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Stewart, M. S. Medow, L. D. Montgomery, and K. McLeod Decreased skeletal muscle pump activity in patients with postural tachycardia syndrome and low peripheral blood flow Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1216 - H1222. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |